2nd Quarter - Report

STARBUCKS CORPORATION for STARBUCKS CORPORATION

Firm
Client
Income
—
Expenses
$130,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Tax proposals regarding the treatment of foreign income, including advocating for a proposal to expand the active royaties exception (no specific bill number).

LobbyistCovered position, as disclosed
LORI OTTO PUNKE —

Contacted: Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); U.S. Trade Representative (USTR); Treasury, Dept of; HOUSE OF REPRESENTATIVES; White House Office; SENATE

Food Industry (safety, labeling, etc.) FOO

PL 111-148 - Patent Protection and Affordable Care Act (PPACA) with respect to implementation of menu labeling requirements.

LobbyistCovered position, as disclosed
LORI OTTO PUNKE —

Contacted: Treasury, Dept of; White House Office; U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS)

Banking BAN

Public Law 111-203 - Dodd-Frank Wall Street Reform and Consumer Protection Act; financial reform related to interchange.

LobbyistCovered position, as disclosed
LORI OTTO PUNKE —

Contacted: Treasury, Dept of; Health & Human Services, Dept of (HHS); White House Office; Food & Drug Administration (FDA); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Health care and health care technology issues including A) Implementation of PL 111-148 - Patent Protection and Affordable Care Act (PPACA); B) implementation of menu labeling requirements; and C) development of health information technologies and its relationship to self-fund health benefit plans (no specific bill number).

LobbyistCovered position, as disclosed
LORI OTTO PUNKE —

Contacted: Treasury, Dept of; SENATE; U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); White House Office; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Trade (domestic/foreign) TRD

Seek the reduction of import duties (and other non-tariff barriers to trade) related to the U.S. Panama Free Trade Agreement (FTA), Colombia FTA, and Korea FTA.

LobbyistCovered position, as disclosed
LORI OTTO PUNKE —

Contacted: HOUSE OF REPRESENTATIVES; Treasury, Dept of; U.S. Trade Representative (USTR); Food & Drug Administration (FDA); SENATE; Health & Human Services, Dept of (HHS); White House Office

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.